While deep brain stimulation is only approved in the U.S. for treatment of Parkinson's disease and other movement disorders, the procedure also shows promise in diseases like obsessive-compulsive disorder, epilepsy and depression.
The procedure, however, is not without risk. According to the American Academy of Neurology, complications are seen in 18 percent of procedures, primarily related to equipment failure or lead migration.
In a recent study of patients with epilepsy, deep brain stimulation reduced their seizures by 40 percent in three months and the reduction in seizures lasted for about one year.
For patients who kept their stimulator on longer, their seizures were reduced by 56 percent at two years and 68 percent at three years, according to the study.
An expert Food and Drug Administration Advisory panel ruled on Friday, March 12, to recommend approval of the deep brain stimulation device for epilepsy that cannot be treated with medications. The FDA could not give information regarding the timeline for an official decision, an FDA spokesperson told ABC News.
Frisch's surgery was not even over when his tremors eased and he gained back control of his hands.
"It was truly remarkable, enough that the entire room broke out in applause," said Frisch.
Although stimulation has reduced the number of tremors, he probably will experience tremors for the rest of his life, according to Lee. But that prognosis has not stopped Frisch, who said his tremors will not rob him of the chance to perform again.
"I fell in love with the violin before I started playing," said Frisch. "Since I was a little boy, playing in the orchestra was all I wanted to do for the rest of my life."